District of Columbia Statutes

§ 44-210 — Cytology screening.

District of Columbia § 44-210
JurisdictionDistrict of Columbia
Title 44Charitable and Curative Institutions.
Ch. 2Clinical Laboratories.

This text of District of Columbia § 44-210 (Cytology screening.) is published on Counsel Stack Legal Research, covering District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
D.C. Code § 44-210 (2026).

Text

The Mayor shall adopt rules pursuant to § 44-213 that:

(1)Limit the number of slides a cytotechnologist may examine to no more than 100 in a 24-hour period, irrespective of the site or clinical laboratory;
(2)Prohibit cytotechnologists from examining slides at any building not owned or used by a licensed clinical laboratory;
(3)Require clinical laboratories to rescreen no less than 10% of all negative pap smears, and require that pap smear rescreening be performed by a supervisory level cytotechnologist;
(4)Require clinical laboratories rescreen all negative noncervical smears, and require that noncervical smear rescreening be performed by a supervisory level pathologist;
(5)Require clinical laboratories to reject improperly prepared smear specimens, make appropriate comments reg

Free access — add to your briefcase to read the full text and ask questions with AI

Legislative History

Mar. 16, 1989, D.C. Law 7-182, § 11, 35 DCR 7718; Oct. 20, 2005, D.C. Law 16-33, § 5012(i), 52 DCR 7503

Nearby Sections

15
View on official source ↗

Cite This Page — Counsel Stack

Bluebook (online)
District of Columbia § 44-210, Counsel Stack Legal Research, https://law.counselstack.com/statute/dc/44-210.